Health Related Quality of Life in stem cell transplantation: Clinical and psychometric validation of the questionnaire module, High Dose Chemotherapy (HDC-19)

Acta Oncologica

Volumn 47, Issue 2, 2008, Pages 275-285

  Andersson, I ^a,d   Hjermstad, M ^b,c   Stockelberg, D ^a   Persson, L O ^d  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

^c Kreftforeningen   (Norway)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; MELPHALAN;

ACUTE LEUKEMIA; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CHRONIC LEUKEMIA; COGNITION; COMBINATION CHEMOTHERAPY; DRUG MEGADOSE; EMOTION; FEMALE; FUNCTIONAL ASSESSMENT; GRAFT VERSUS HOST REACTION; HEALTH STATUS; HIGH DOSE CHEMOTHERAPY QUESTIONNAIRE 19; HUMAN; LANGUAGE; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NORWAY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SEXUAL DYSFUNCTION; SOCIAL INTERACTION; SOLID TUMOR; STEM CELL TRANSPLANTATION; SWEDEN; SYMPTOM; TASTE DISCRIMINATION; TREATMENT OUTCOME; VALIDITY; WHOLE BODY RADIATION; XEROSTOMIA;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PSYCHOLOGICAL TESTS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; STEM CELL TRANSPLANTATION; TIME FACTORS;

EID: 38349177283     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860701558799     Document Type: Article

References (27)

1. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A. EBMT activity survey 2004 and changes in the disease indication over the past 15 years. Bone Marrow Transplant 2006;37:1069-85.
2. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H, et al. Allogeneic and autologous transplantation for haematological diseases, solid tumors and immune disorders: Definition and current practice in Europe. Bone Marrow Transplant 2006;37:439-49.
3. Bakitas WM. In: Wujcik D, editor. Blood and marrow stem-cell transplantation. Indications, procedure, process. Sudbury: Jones & Bartlett Publishers; 1997.
4. Sanders JE. Chronic graft-versus-host disease and late effects after hematopoetic stem cell transplantation. Int J Hematol 2002;76(Suppl 2):15-28.
5. Tabbara IA, Zimmerman K, Morgan C, Nahleh Z. Allogeneic hematopoetic stem cell transplantation: Complications and result. Arch Intern Med 2002;162:1558-66.
6. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N, et al. The European organisation for research and treatment of cancer: A quality-of-life instrument for use in international clinical trials in oncology. I Natl Cancer Inst 1993;85:365-76.
7. Muldon M, Barger J, Manuck S. What are quality of life measurements measuring? BMJ 1998;316:542-5.
8. Sprangers M. Quality of life assessment in oncology. Acta Oncol 2002;41:229-37.
9. Bjordal K, Ahlner-Elmqvist M, Tollesson EA, Razavi D, Maher E, Kaasa S. Development of a European organisation for research and treatment of cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. Acta Oncol 1994;33:879-85.
10. Blazeby JM, Alderson D, Winstone K, Steyn R, Hammerlid E, Arraras J, et al. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. Eur J Cancer 1996;32:1912-7.
11. Sprangers M, Groenvold M, Arras J, Franklin J, te Velde A, Muller M, et al. The EORTC breast-cancer specific quality-of-life questionnaire (QLQ-BR23): First results from a three-country field study. J Clin Oncol 1996;14:2756-68.
12. Sprangers M, te Velde A, Aaronson A. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-QR38). Eur J Cancer 1999;35:238-47.
13. Blazeby JM, Conroy T, Bottomley A, Vickery C, Arrars J, Sezer O, et al. on behalf of the European organisation for research and treatment of cancer gastrointestinal and quality of life groups. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO22, to assess quality of life in patients with gastric cancer. Eur J Cancer 2004;40:2260-8.
14. Sprangers M, Cull A, Bjordal K, Groenvold M, Aaronson NK. The European organization for research and treatment of cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Qual Life Res 1993;2:287-95.
15. Hjermstad M, Holte H, Evensen S, Fayers P, Kaasa S. Do patients who are treated with stem cell transplantation have a health related quality of life comparable to the general population after 1 year? Bone Marrow Transplant 1999a;24:911-8.
16. Velikova G, Weis J, Hjermstad M, Kopp M, Morris P, Watson M, et al. The EORTC QLQ-HDC29: A supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. Eur J Cancer 2007;43:87-94.
17. EORTC Quality of life study group. EORTC QLQ-C30 scoring manual, 3rd ed. Brussels: EORTC; 2001.
18. Gorsuch RL. Factor analysis. Hillsdale NJ: Lawrenece Erlbaum Associates; 1983.
19. Hays RD, Hayashi T, Carson S, Ware JE. User's guide for the multi-trait analysis program (MAP). The Rand Publication series; 1988.
20. Fayers PM, Machin D. Quality of life: Assessment, analysis and interpretation. Chichester UK: John Wiley & Sons; 2001.
21. Altman DG. Practical statistics for medical research. London: Chapman and Hall; 1991.
22. Cohen J. Statistical power analysis for the behavioural sciences. Hillsdale NJ: Lawrence Earlbaum; 1988.
23. Edman L, Larsen J, Hägglund H, Gardulf A. Health-related quality of life, symptom distress and sense of coherence in adult survivors of allogenic stem-cell transplantation. Eur Cancer Care 2001;10:124-30.
24. Molassiotis A, Morris P. Quality of life in patients with chronic myeloid leukaemia after unrelated donor bone marrow transplantation. Cancer Nurs 1999;22:340-9.
25. Broers S, Kaptein A, Saskia L, Fibbe W, Hengeveld M. Psychological functioning and quality of life following bone marrow transplantation: A 3-year follow-up study. J Psychosom Res 2000;48:11-21.
26. Hjermstad M, Evensen S, Kvaloy S, Fayers P, Kaasa S. Health-related quality of life 1 year after allogenic or autologous stem-cell transplantation: A prospective study. J Clin Oncol 1999b;17:706-18.
27. Hjermstad M, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, et al. A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation. Bone Marrow Transplant 2004;34:257-66.